Interstitial lung diseases

M Wijsenbeek, A Suzuki, TM Maher - The Lancet, 2022 - thelancet.com
Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

State-of-the-art evidence in the treatment of systemic sclerosis

JE Pope, CP Denton, SR Johnson… - Nature Reviews …, 2023 - nature.com
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with multi-organ
involvement, fibrosis and vasculopathy. Treatment in SSc, including early diffuse cutaneous …

Treatment of systemic sclerosis–associated interstitial lung disease: evidence-based recommendations. an official american thoracic society clinical practice guideline

G Raghu, SB Montesi, RM Silver, T Hossain… - American journal of …, 2024 - atsjournals.org
Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …

Fibroblast activation protein–specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study

M Röhrich, D Leitz, FM Glatting… - Journal of nuclear …, 2022 - jnm.snmjournals.org
Interstitial lung diseases (ILDs) comprise over 200 parenchymal lung disorders. Among
them, fibrosing ILDs, especially idiopathic pulmonary fibrosis, are associated with a poor …

Nintedanib in patients with autoimmune disease–related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial

EL Matteson, C Kelly, JHW Distler… - Arthritis & …, 2022 - Wiley Online Library
Objective To analyze the efficacy and safety of nintedanib in patients with fibrosing
autoimmune disease–related interstitial lung diseases (ILDs) with a progressive phenotype …

[HTML][HTML] Lung-function trajectories in COVID-19 survivors after discharge: a two-year longitudinal cohort study

H Zhang, X Li, L Huang, X Gu, Y Wang, M Liu… - …, 2022 - thelancet.com
Background Data on the long-term trajectories of lung function are scarce in COVID-19
survivors. Methods We re-analyzed the data from a prospective longitudinal cohort follow-up …

Acute exacerbation of interstitial lung disease associated with rheumatic disease

F Luppi, M Sebastiani, C Salvarani… - Nature Reviews …, 2022 - nature.com
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …

Potential of photon-counting detector CT for radiation dose reduction for the assessment of interstitial lung disease in patients with systemic sclerosis

L Jungblut, A Euler, J von Spiczak… - Investigative …, 2022 - journals.lww.com
Objective The aim of this study was to determine the potential of photon-counting detector
computed tomography (PCD-CT) for radiation dose reduction compared with conventional …

Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis

J Schniering, M Maciukiewicz… - European …, 2022 - publications.ersnet.org
Background Radiomic features calculated from routine medical images show great potential
for personalised medicine in cancer. Patients with systemic sclerosis (SSc), a rare …

Biomarkers in the pathogenesis, diagnosis, and treatment of systemic sclerosis

M Muruganandam, A Ariza-Hutchinson… - Journal of …, 2023 - Taylor & Francis
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by vascular
damage, vasoinstability, and decreased perfusion with ischemia, inflammation, and …